UPDATE 1-VBI hepatitis B vaccine meets main goals in late-stage trial
June 17, 2019 at 06:33 AM EDT
VBI Vaccines Inc said on Monday a late-stage study testing its hepatitis B vaccine against GlaxoSmithKline's Engerix-B met its main goals.
